“I just cannot take medication for the rest of my life”: Non adherence Towards Diabetes Treatment
DOI:
https://doi.org/10.37506/b8v47a31Keywords:
Type 2 diabetes, non adherence, non compliance, health behaviour, health beliefsAbstract
Diabetes is a rapidly growing health challenge and potential epidemic across the low-and-middle-income countries. In primary health care settings, the management of diabetes is mainly by providing hypoglycemic drugs and lifestyle change. The level of adherence and compliance to the therapy is a critical element in glycaemic control. In developed countries, adherence to long-term therapies in the general population is around 50% and is much lower in developing countries. A specific trend of non compliance and non adherence towards medication was seen in patients coming to a rural primary health care facility in India. Several beliefs regarding non adherence were identified in such patients which are - Beliefs about chronic diseases in general, beliefs about long term drug intake, behavior towards diabetes medication, peers observations and switching between different treatments. There is a need to identify specific reasons for non compliance and/or non adherence so that more focused behavioral change strategies can be made for patients of chronic diseases.
References
Misra A, Gopalan H, Jayawardena R, Hills AP, Soares M and Reza-Albarrán AA, et al. Diabetes in developing countries. J Diabetes. 2019;11:522–39.
International Diabetes Federation. IDF Diabetes Atlas, 10th edn. Brussels, Belgium: International Diabetes Federation [Internet] 2021. [Assessed on 27th January 2024]Available from : https://diabetesatlas.org/idfawp/resource-files/2021/11/IDF-Atlas-
Factsheet-2021_SEA.pdf
Ayub A, Behera B. K. and Meher, D. Compliance with the treatment of diabetes mellitus and the factors associated. International Journal of Health Sciences. 2022;6(S3):7423–32.
Khattab M, Khader YS, Al-Khawaldeh A and Ajlouni K. Factors associated with poor glycemic control among patients with Type 2 diabetes. Journal of Diabetes and Its Complications. 2010;24:84-9.
Mukherjee S, Sharmasarkar B, Das KK, Bhattacharyya A and Deb A. Compliance to anti-diabetic drugs: observations from the diabetic clinic of a medical college in Kolkata, India. J ClinDiagn Res. 2013;7(4):661-5.
World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization. 2003. [Internet] [Assessed on 27th January 2024] Available from :http://apps.who.int/medicinedocs/pdf/s4883e/s4883e.pdf]
E. Sabaté, Adherence to Long-Term Therapies: Evidence for Action. World Health Organization, Geneva, Switzerland, 2003.
Sackett D.L., Haynes R.B., and Gibson E.S. Patient compliance with antihypertensive regimens. Patient Counselling and Health Education. 1978;1(1):18–21.
Horne R, Weinman J, Barber N, Elliott R, Morgan M. Concordance, ad-herence and compliance in medicine taking. A Report for the National Co-ordinating Centre for NHS Service Delivery and Organisation R&D. London, 2005. Available from: http://www.netscc.ac.uk/hsdr/files/pro-ject/SDO_FR_08-1412-076_V01.pdf.
World Health Organisation. Failure to take prescribed medicine for chronic diseases is a massive, world-wide problem. WHO, Geneva. [Internet] [Assessed on 28th January 2024] Available from: https://www.who.int/news/item/01-07-2003-failure-to-take-prescribed-medicine-for-chronic-diseases-is-a-massive-world-wide-problem
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Dr. Priya Kataria
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
